Corbus Pharmaceuticals Holdings Overview
Corbus Pharmaceuticals Holdings Discounted Cash Flow
DCF Analysis for CRBP.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.02
Current Fair Value
$2.02
↓ 75.8% Downside
Overvalued by 75.8% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison